Literature DB >> 1002003

Factor-VIII-related antigen and cold-insoluble globulin in leukemias and carcinomas.

H D Bruhn, N Heimburger.   

Abstract

An elevated plasma level of the factor-VIII-related antigen is not specific for leukemias and malignancies but is also observed in inflammations and in rheumatic diseases. As a reason for this nonspecific change an increased tissue breakdown has to be considered as well as an impaired elimination of the protein, possibly in some cases in the course of a consumption coagulopathy. The plasma levels of the cold-insoluble globulin were reduced in chronic lymphatic leukemias and in acute inflammations, but elevated in rheumatic diseases. Production and liberation of the cold-insoluble globulin may not only be changed by malignant transformation of cells but also by inflammatory and infectious processes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002003     DOI: 10.1159/000214134

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  9 in total

1.  Problems in the detection of carriers of hemophilia A: the influence of stress and thrombin.

Authors:  U Göbel; R von Kries; H Jürgens; H von Voss
Journal:  Blut       Date:  1978-07-14

2.  Plasma fibronectin in normal subjects and in various disease states.

Authors:  N E Stathakis; A Fountas; E Tsianos
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.

Authors:  M Reitz; G Witzke; R Egbring; P Gutjahr
Journal:  Klin Wochenschr       Date:  1984-12-17

4.  [Fibronectin].

Authors:  E Klar; D L Heene
Journal:  Klin Wochenschr       Date:  1984-10-15

5.  Immunohistochemical study of fibronectin in human glioma and meningioma.

Authors:  N Kochi; E Tani; T Morimura; T Itagaki
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

6.  Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.

Authors:  C Haglund; S Ylätupa; P Mertaniemi; P Partanen
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Milieu matters: An in vitro wound milieu to recapitulate key features of, and probe new insights into, mixed-species bacterial biofilms.

Authors:  Snehal Kadam; Vandana Madhusoodhanan; Radhika Dhekane; Devyani Bhide; Rutuja Ugale; Utkarsha Tikhole; Karishma S Kaushik
Journal:  Biofilm       Date:  2021-04-03

8.  Cellular fibronectin in serum and plasma: a potential new tumour marker?

Authors:  S Ylätupa; C Haglund; P Mertaniemi; E Vahtera; P Partanen
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

9.  Glycoproteomic Analysis Reveals Aberrant Expression of Complement C9 and Fibronectin in the Plasma of Patients with Colorectal Cancer.

Authors:  Juthamard Chantaraamporn; Voraratt Champattanachai; Amnart Khongmanee; Chris Verathamjamras; Naiyarat Prasongsook; Kanokwan Mingkwan; Virat Luevisadpibul; Somchai Chutipongtanate; Jisnuson Svasti
Journal:  Proteomes       Date:  2020-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.